Paclitaxel (Albumin-bound) Combined With Oxaliplatin and S-1 Conversion Therapy for Gastric Adenocarcinoma
Clinical trial NCT04047953 · RECRUITING
Trial details
- NCT number
- NCT04047953
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-10
- Primary completion
- 2023-12-31
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.